Clinical Trial Update: SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE) [Phase 2]

View source ↗

Summary

Phase 2 trial of SYN120 in Parkinson's Disease Dementia has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease Dementia
• Parkinson Disease with Dementia

Drugs mentioned

• SYN120 (unknown)

Snippet

Sponsor: Biotie Therapies Inc. | Conditions: Parkinson's Disease Dementia (PDD) | Phase 2 | Status: COMPLETED | Results posted: 2019-04-19